Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma

Clinical Microbiology and Infection

Volumn 22, Issue 2, 2016, Pages 178.e11-178.e22

  Aviles Jimenez F ^a   Guitron, A ^b   Segura Lopez F ^b   Mendez Tenorio A ^c   Iwai, S ^d   Hernandez Guerrero A ^e   Torres, J ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UMAE 71 IMSS   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d Second Genome   (United States)

^e INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Benign stenosis; Cholangiocarcinoma; Helicobacter pylori; Microbiota; Nesterenkonia; Novosphingobium

Indexed keywords

RNA 16S; BACTERIAL RNA;

ACTINOMYCES; ADULT; AGED; ARTICLE; BACTERIAL VIRULENCE; BENIGN BILIARY PATHOLOGY; BILE DUCT; BILE DUCT CARCINOMA; BILIARY TRACT DISEASE; CONTROLLED STUDY; DNA EXTRACTION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXTRAHEPATIC CHOLANGIOCARCINOMA; FEMALE; FUSOBACTERIUM; GENE SEQUENCE; HELICOBACTER PYLORI; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MESORHIZOBIUM; METHYLOPHILACEAE; MIDDLE AGED; PHYLUM; PREVOTELLA; PRIORITY JOURNAL; VERY ELDERLY; CLASSIFICATION; GENETICS; HELICOBACTER INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; PHYLOGENY; PROTEOBACTERIA; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCTS; CHOLANGIOCARCINOMA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; PHYLOGENY; PROTEOBACTERIA; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

EID: 84960483410     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.10.008     Document Type: Article

References (49)

1. Kawarada Y., Yamagiwa K., Das B.C. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 2002, 183:679-685.
2. Andia M.E., Hsing A.W., Andreotti G., et al. Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study. Int J Cancer 2008, 123:1411-1416.
3. Zhou D., Wang J.D., Weng M.Z., et al. Infections of Helicobacter spp. in the biliary system are associated with biliary tract cancer: a meta-analysis. Eur J Gastroenterol Hepatol 2013, 25:447-454.
4. Fallone C.A., Tran S., Semret M., et al. Helicobacter DNA in bile: correlation with hepato-biliary diseases. Aliment Pharmacol Ther 2003, 17:453-458.
5. Murata H., Tsuji S., Tsujii M., et al. Helicobacter bilis infection in biliary tract cancer. Alim Pharmacol Ther 2004, 20:90-94.
6. Segura-López F.K., Avilés-Jiménez F., Güitrón-Cantú A., et al. Infection with Helicobacter bilis but not Helicobacter hepaticus was associated with extrahepatic cholangiocarcinoma. Helicobacter 2015, 20:223-230.
7. Apostolov E., Al-Soud W.A., Nilsson I., et al. Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods. Scand J Gastroenterol 2005, 40:96-102.
8. Kobayashi T., Harada K., Miwa K., et al. Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig Dis Sci 2005, 50:862-867.
9. Kosaka T., Tajima Y., Kuroki T., et al. Helicobacter bilis colonization of the biliary system in patients with pancreaticobiliary maljunction. Br J Surg 2010, 97:544-549.
10. Sithithaworn P., Yongvanit P., Duenngai K., et al. Roles of liver fluke infection as risk factor for cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014, 21:301-308.
11. Hosgood H.D., Sapkota A.R., Rothman N., et al. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures. Environ Mol Mutagen 2014, e-pub ahead of print 3 June 2014. 10.1002/em.21878.
12. Schmidt B.L., Kuczynski J., Bhattacharya A., et al. Changes in abundance of oral microbiota associated with oral cancer. PLoS ONE 2014, 9:e98741.
13. Wu N., Yang X., Zhang R., et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 2013, 66:462-470.
14. Castellarin M., Warren R.L., Freeman J.D., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012, 22:299-306.
15. Sobhani I., Tap J., Roudot-Thoraval F., et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 2011, 6:e16393.
16. McDonald D., Price M.N., Goodrich J., et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012, 6:610-618.
17. DeSantis T.Z., Hugenholtz P., Larsen N., et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006, 72:5069-5072.
18. Langille M.G., Zaneveld J., Caporaso J.G., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013, 31:814-821.
19. Compeau P., Pevzner Bioinformatics algorithms: an active learning approach 2014, Bioinformatics Algorithms: An Active Learning Approach. Active Learning Publishers, (ISBN-10: 0990374602, ISBN-13: 978-0990374602).
20. Guitart-Pla O., Kustagi M., Rügheimer F., et al. The Cyni framework for network inference in Cytoscape. Bioinformatics 2015, 31:1499-1501.
21. Margolin A.A., Nemenman I., Basso K., et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinform 2006, 7(Suppl. 1):S7.
22. Margolin A.A., Wang K., Lim W.K., et al. Reverse engineering cellular networks. Nat Protoc 2006, 1:662-671.
23. Atherton J.C., Cover T.L., Twells R.J., et al. Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol 1999, 37:2979-2982.
24. Yamaoka Y., Kodama T., Kashima K., et al. Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 1998, 36:2258-2263.
25. Avilés-Jiménez F., Reyes-Leon A., Nieto-Patlán E., et al. In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer. Infect Immun 2012, 80:594-601.
26. Zhi X., Yang L., Wang Y., et al. Genus-specific PCR for molecular identification of novel isolates of the genus Nesterenkonia. Acta Microbiol Sinica 2008, 48:644-650.
27. Wu T., Zhang Z., Liu B., et al. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics 2013, 14:669.
28. Aviles-Jimenez F., Vazquez-Jimenez F., Medrano-Guzman R., et al. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep 2014, 4:4202.
29. Kamada N., Chen G.Y., Inohara N., et al. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013, 14:685-690.
30. Tan J., McKenzie C., Potamitis M., et al. The role of short-chain fatty acids in health and disease. Adv Immunol 2014, 121:91-119.
31. Foglietta F., Serpe L., Canaparo R., et al. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines. J Pharm Pharm Sci 2014, 17:231-247.
32. Yang L., Francois F., Pei Z. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus. Clin Cancer Res 2012, 18:2138-2144.
33. Yu G., Gail M.H., Shi J., et al. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev 2014, 23:735-741.
34. Aliyu H., De Maayer P., Rees J., et al. Draft genome sequence of the Antarctic polyextremophile Nesterenkonia sp. strain AN1. Genome Announc 2014, 2:e00197-142.
35. Collins M.D., Lawson P.A., Labrenz M., et al. Nesterenkonia lacusekhoensis sp. nov., isolated from hypersaline Ekho Lake, East Antarctica, and emended description of the genus Nesterenkonia. Int J Syst Evol Microbiol 2002, 52:1145-1150.
36. Szczerba I., Krzemiński Z. Occurrence of bacteria in the mouth from genera of Micrococcus, Kocuria, Nesterenkonia, Kytococcus and Dermacoccus. Med Dosw Mikrobiol 2002, 54:29-34.
37. Szczerba I. Occurrence and number of bacteria from the Micrococcus, Kocuria, Nesterenkonia, Kytococcus and Dermacoccus genera on skin and mucous membranes in humans. Med Dosw Mikrobiol 2003, 55:67-74.
38. Lo S.C., Li B., Hung G.C., et al. Isolation and characterization of two novel bacteria Afipia cberi and Mesorhizobium hominis from blood of a patient afflicted with fatal pulmonary illness. PloS ONE 2013, 8:e82673.
39. Eyice Ö., Namura M., Chen Y., et al. SIP metagenomics identifies uncultivated Methylophilaceae as dimethylsulphide degrading bacteria in soil and lake sediment. ISME J 2015 Mar 27.
40. Ahn J., Yang L., Paster B.J., et al. Oral microbiome profiles: 16S rRNA pyrosequencing and microarray assay comparison. PLoS ONE 2011, 6:e22788.
41. Olafsson S., Gudjonsson H., Selmi C., et al. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol 2004, 99:2143-2146.
42. Kaplan M.M. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am J Gastroenterol 2004, 99:2147-2149.
43. Mohammed J.P., Mattner J. Autoimmune disease triggered by infection with alphaproteobacteria. Exp Rev Clin Immunol 2009, 5:369-379.
44. Myung S.J., Kim M.H., Shim K.N., et al. Detection of Helicobacter pylori DNA in human biliary tree and its association with hepatolithiasis. Dig Dis Sci 2000, 45:1405-1412.
45. Boonyanugomol W., Chomvarin C., Sripa B., et al. Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB (Oxford) 2012, 14:177-184.
46. Morrison M.J., Imperiali B. The renaissance of bacillosamine and its derivatives: pathway characterization and implications in pathogenicity. Biochemistry 2014, 53:624-638.
47. Plottel C.S., Blaser M.J. Microbiome and malignancy. Cell Host Microbe 2011, 10:324-335.
48. Cavalieri E., Chakravarti D., Guttenplan J., et al. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 2006, 1766:63-78.
49. Salter S.J., Cox M.J., Turek E.M., et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 2014, 12:87.